Now I have a comprehensive calibration picture. Let me finalize the review.

## Summary
This paper introduces the task of PPI candidate ranking — prioritizing novel interaction candidates for experimental validation — and proposes a two-stage framework: (1) interpretability-guided retrieval using active embedding regions from predicted contact maps of known interaction partners, and (2) re-ranking using multiple biological signals (interaction scores, structural plausibility, functional annotations, biomedical language models). Evaluated prospectively on STRING v11→v12 (279,568 novel positives), the method substantially improves ranking metrics over raw prediction probabilities from D-SCRIPT, Topsy-Turvy, and xCAPT5.

## Strengths
1. **Well-motivated problem formulation.** The paper reframes PPI prediction from retrospective classification to prospective candidate ranking, which is more practically aligned with the goal of guiding experimental validation. This is a genuine re-framing of the evaluation target (Section 1, lines 20–22).
2. **Prospective evaluation design using STRING v11→v12.** Holding out interactions that only appear in a later database release is the right methodology for testing whether a method can anticipate genuinely new discoveries. The scale — 279,568 novel positives — is substantial (Section 5.1).
3. **Clever technical idea.** Selecting active residue regions from predicted contact maps of known interaction pairs and using those to anchor cosine-similarity comparisons is motivated by a clear biological intuition and is the paper's core methodological innovation (Section 4.1, Equation 3).
4. **Large-scale multi-faceted evaluation.** The evaluation covers many metrics (Recall, Precision, MAP, nDCG, Success, MRR) at multiple cutoffs (k=5 to 500), and the re-ranking analysis compares ten different signals pairwise (Table 2).

## Weaknesses

### Fatal
None.

### Major
1. **"Two orders of magnitude" claim is unsupported by the data.** The paper states at lines 25 and 279 that the framework improves ranking metrics by "up to two orders of magnitude" (~100×). The largest observed improvement in Table 1 is Recall@5 for D-SCRIPT (0.0071 → 0.1832, a ~26× gain). MRR improves ~5×, MAP@5 ~26×. No metric approaches 100×. The actual gains are substantial (20–26× in the best case) but an order of magnitude short of what is claimed. This overstatement appears in the introduction and conclusion, which are the most visible parts of the paper, and undermines reader trust in the reported numbers.

2. **Missing ablation disentangling the core mechanism from known-partner conditioning.** The baselines (D-SCRIPT, Topsy-Turvy, xCAPT5) rank candidates by raw prediction probability, without access to known-partner information. The proposed method uses known partners KP(p) as anchors. This conflates two sources of gain: (a) the specific active-residue embedding selection mechanism, and (b) the general benefit of conditioning on known partners. Without an ablation comparing against full-embedding cosine similarity (no active-residue masking) or a known-partner-averaged prediction score, the paper cannot substantiate its core claim — that *interpretability-guided* embedding selection specifically drives the improvement rather than simply using known-partner information in any reasonable way.

3. **No end-to-end evaluation of the re-ranking pipeline.** The re-ranking analysis (Table 2) is limited to pairwise rank-shift comparisons between individual signals. The paper claims re-ranking "is crucial to refine the initial embedding-based ranking" (line 23), but never presents end-to-end metrics (MRR, Recall@k, Success@k) for the full pipeline after re-ranking. Since re-ranking operates only on the top-10 candidates (line 109), metrics at k > 10 are unaffected by re-ranking. The pairwise analysis shows that signals change the order but does not demonstrate that they improve discovery in terms that matter for the stated practical goal.

### Minor
4. **PubMedBERT cross-encoder evaluation involves potential circularity.** The cross-encoder is fine-tuned on STRING v11 interaction labels using protein text profiles. Since STRING v11 labels partly derive from text-mining evidence, the cross-encoder may learn to recognize textual patterns that STRING's pipeline uses to label interactions. The paper partially acknowledges this for BioBERT and BioMedRoBERTa (lines 263–264) but the concern extends even more forcefully to PubMedBERT, which was explicitly fine-tuned on STRING v11. This does not affect the main retrieval results (Table 1) but weakens the re-ranking conclusions.

5. **xCAPT5 embeddings not tested with the proposed method.** The interpretability-guided retrieval is applied only to D-SCRIPT and Topsy-Turvy (which share the Bepler & Berger encoder). xCAPT5 serves only as a baseline, limiting generality claims — the method may only work with models producing interpretable contact maps from that specific encoder architecture.

6. **No analysis of failure cases.** The paper acknowledges dependence on known partners for underexplored proteins (Section 6, lines 284–289) but does not quantify how performance varies with the number of known partners per protein. Understanding this relationship is important for practical deployment.

7. **Re-ranking analysis uses only 2,280 protein-candidate pairs** (line 227), a modest subset of the full evaluation. The representativeness of this subset is not discussed.

### Trivial
- Table 2 caption is incomplete: "and ‡ is reported" does not specify what ‡ represents.

## Nice-to-Haves
- Full-embedding cosine similarity (without active-residue masking) and known-partner-averaged prediction score baselines to isolate the active-residue contribution.
- End-to-end metrics (MRR, Recall, Success) for at least one combined re-ranking configuration.
- Analysis correlating performance with the number of known partners per protein.
- Error bars or confidence intervals, though the large evaluation set likely provides stability.

## Removed Points
These points were identified by reviewers but are removed from the main review with justification:
- **"No error bars / significance tests"**: Demoted to nice-to-have; single-run evaluation on large-scale benchmarks is standard in this subfield.
- **Parser artifact criticisms (line 53 "An example", line 233 garbled text)**: Removed per hard rules — these are PDF extraction artifacts, not author errors.
- **Missing related works**: Removed per hard rules — cannot verify existence of unmentioned works.
- **Criticism about xCAPT5 having higher Precision@5**: The asymmetry favors the baseline (0.1943 vs. 0.1924), which is permissible per rules. The reviewer's own numbers show this.
- **"The comparison is unfair because baselines lack known partners"**: This is actually a valid criticism, not an "unfair comparison" per se — it's a missing ablation, not a fairness complaint. Kept in Major as weakness #2.

## Novel Insights
None beyond the paper's own contributions.

## Suggestions
1. **Correct the "two orders of magnitude" claim** in the introduction and conclusion to match the actual effect sizes (peak ~26×), which are still substantial and do not need to be overstated.
2. **Add a full-embedding cosine similarity baseline** (no active-residue masking) and a known-partner-averaged prediction score to isolate the contribution of the active-residue selection mechanism.
3. **Report end-to-end metrics** for at least one re-ranking configuration (e.g., initial retrieval + PubMedBERT re-ranking).
4. **Quantify how performance varies** with the number of known partners per protein.
5. **Acknowledge the circularity concern** for PubMedBERT more thoroughly.

## Score and Decision

### Calibration Anchors

| Anchor Paper | Path | Avg Score | Round | Itemized | Comparison |
|---|---|---|---|---|---|
| PPI design with generalization | xcMmebCT7s | 5.80 | 1 | Yes | My paper avoids its fatal issues (no code/data, small test set) but has overclaiming and missing ablation. Slightly stronger. |
| Protein function via similarity | jsQPjIaNNh | 5.25 | 1 | Yes | My paper has clearer evaluations and fewer missing baselines. Stronger. |
| Microenvironment PPI | itGkF993gz | 5.67 | 1 | Yes | Missing references and confusing claims in that anchor compensate each other; comparable overall but my evaluation is cleaner. |
| LLaPA for PPI | eh1fL0zw8o | 6.00 | 2 | Yes | Has theoretical error (-4) and data leakage (-4), which are more severe than my paper's weaknesses. My paper is stronger. |
| Enzyme promiscuity | 760br3YEtY | 5.60 | 2 | Yes | Primarily a novelty-limitation paper; my paper's problem framing is more novel. Stronger. |
| Bioactivity prediction | S8gbnkCgxZ | 7.00 | 2 | Yes | Very strong contributions with mostly minor weaknesses; my paper's weaknesses (overclaiming, missing ablation) are more significant. Weaker. |

**Calibration reasoning.** Round 1 bracketing placed the paper between 4.5 and 6.5. Round 2 narrowed to 5.5–6.5 by comparing itemized anchors. The paper is stronger than 5.25–5.80 anchors (which have fatal-grade weaknesses like missing code/data, data leakage, theoretical errors) and weaker than the 7.00 anchor (which has only minor weaknesses). The closest comparative anchor is the 6.00 LLaPA paper, whose weaknesses (theoretical error -4, data leakage -4) are more severe than this paper's (overclaiming -3, missing ablation -3, incomplete evaluation -2). However, the LLaPA paper also has stronger positive weights (+3, +3, +3) than this paper's strengths. The weighted-item comparison places this paper marginally below that anchor's 6.00 because the LLaPA paper's claimed SOTA and novel knowledge injection method receive higher positive weights (+3 each) than the PPI candidate ranking paper's strengths, while the severity of the two papers' negative items is comparable in magnitude.

**Final Score: 6.0** — Borderline accept. The paper makes a genuine contribution through its problem framing and clever technical approach, with a well-designed prospective evaluation. However, the overclaimed results and the missing ablation for the core mechanism prevent a higher score. These issues are fixable with straightforward corrections and additional experiments.

MY FINAL SCORE: <score>6.0</score>
MY FINAL DECISION: <decision>Accept</decision>